The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation
- PMID: 33200842
- PMCID: PMC7744920
- DOI: 10.1002/bies.202000240
The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation
Abstract
Severe acute respiratory syndrome-coronavirus (SARS-CoV)-2's origin is still controversial. Genomic analyses show SARS-CoV-2 likely to be chimeric, most of its sequence closest to bat CoV RaTG13, whereas its receptor binding domain (RBD) is almost identical to that of a pangolin CoV. Chimeric viruses can arise via natural recombination or human intervention. The furin cleavage site in the spike protein of SARS-CoV-2 confers to the virus the ability to cross species and tissue barriers, but was previously unseen in other SARS-like CoVs. Might genetic manipulations have been performed in order to evaluate pangolins as possible intermediate hosts for bat-derived CoVs that were originally unable to bind to human receptors? Both cleavage site and specific RBD could result from site-directed mutagenesis, a procedure that does not leave a trace. Considering the devastating impact of SARS-CoV-2 and importance of preventing future pandemics, researchers have a responsibility to carry out a thorough analysis of all possible SARS-CoV-2 origins.
Keywords: BtCov/4991; Gain-of-function studies; RaTG13; SARS-CoV-2; furin cleavage site; pangolin CoV; receptor binding domain.
© 2020 The Authors. BioEssays published by Wiley Periodicals LLC.
Conflict of interest statement
Rossana Segreto and Yuri Deigin do not have any conflicts of interest.
Figures
Comment in
-
There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (DOI: 10.1002/bies.202000240).Bioessays. 2021 May;43(5):e2000325. doi: 10.1002/bies.202000325. Epub 2021 Mar 9. Bioessays. 2021. PMID: 33751609 Free PMC article.
Similar articles
-
SARS-CoV-2's claimed natural origin is undermined by issues with genome sequences of its relative strains: Coronavirus sequences RaTG13, MP789 and RmYN02 raise multiple questions to be critically addressed by the scientific community.Bioessays. 2021 Jul;43(7):e2100015. doi: 10.1002/bies.202100015. Epub 2021 May 27. Bioessays. 2021. PMID: 34046923 Free PMC article.
-
The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789.BMC Res Notes. 2020 Aug 27;13(1):398. doi: 10.1186/s13104-020-05242-8. BMC Res Notes. 2020. PMID: 32854762 Free PMC article.
-
A second functional furin site in the SARS-CoV-2 spike protein.Emerg Microbes Infect. 2022 Dec;11(1):182-194. doi: 10.1080/22221751.2021.2014284. Emerg Microbes Infect. 2022. PMID: 34856891 Free PMC article.
-
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70. Vopr Virusol. 2020. PMID: 32515561 Review. Russian.
-
SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.J Basic Microbiol. 2021 Mar;61(3):180-202. doi: 10.1002/jobm.202000537. Epub 2021 Jan 18. J Basic Microbiol. 2021. PMID: 33460172 Free PMC article. Review.
Cited by
-
SARS-CoV-2 origin, myths and diagnostic technology developments.Egypt J Med Hum Genet. 2022;23(1):42. doi: 10.1186/s43042-022-00255-3. Epub 2022 Mar 4. Egypt J Med Hum Genet. 2022. PMID: 37521834 Free PMC article. Review.
-
SARS-CoV-2 in brief: from virus to prevention.Osong Public Health Res Perspect. 2022 Dec;13(6):394-406. doi: 10.24171/j.phrp.2022.0155. Epub 2022 Nov 28. Osong Public Health Res Perspect. 2022. PMID: 36617546 Free PMC article.
-
An efficacy and safety report based on randomized controlled single-blinded multi-centre clinical trial of ZingiVir-H, a novel herbo-mineral formulation designed as an add-on therapy in adult patients with mild to moderate COVID-19.PLoS One. 2022 Dec 6;17(12):e0276773. doi: 10.1371/journal.pone.0276773. eCollection 2022. PLoS One. 2022. PMID: 36472969 Free PMC article. Clinical Trial.
-
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19.J Allergy Clin Immunol Pract. 2023 Jan;11(1):181-186. doi: 10.1016/j.jaip.2022.10.002. Epub 2022 Oct 12. J Allergy Clin Immunol Pract. 2023. PMID: 36241155 Free PMC article.
-
Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin.Int J Biol Macromol. 2022 Dec 1;222(Pt A):972-993. doi: 10.1016/j.ijbiomac.2022.09.184. Epub 2022 Sep 26. Int J Biol Macromol. 2022. PMID: 36174872 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
